NCT06427590View on ClinicalTrials.gov

A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Healthy and Obese Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 13, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Chronic Weight Management

Interventions

DRUG

ASC47

single subcutaneous injection of ASC47

DRUG

Matching placebo

single subcutaneous injection of Placebo

Trial Locations (1)

4006

Ascletis, Herston

All Listed Sponsors

lead

Ascletis Pharma (China) Co., Limited

INDUSTRY

NCT06427590 - A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Healthy and Obese Subjects | Biotech Hunter | Biotech Hunter